drugset / Trial / NCT02825849

Platelet-rich Plasma (PRP) for Endometrial Regeneration and Repair

NCT02825849

Phase 2 Terminated 27 enrolled University of California, San Francisco
RandomizedParallel-groupOpen-labelTreatment

Summary

Patients with intrauterine adhesions (Asherman's Syndrome) and persistent thin endometrial lining in in vitro fertilization (IVF) treatment programs, particularly those resistant to standard therapies, present a significant clinical challenge. The aim of this trial is to assess if intrauterine administration of platelet rich plasma (PRP) improves endometrial lining thickness in patients with thin lining or Asherman's Syndrome.

Timeline

Start
2016-11
Primary completion
2019-08
Completion
2019-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified Other